Voyager Therapeutics VYGR
NASDAQ VYGR
$1.76 -0.07 (-3.56%)
At close: Nov 11, 2026 · 4:00 PM EST

Voyager Therapeutics (VYGR) Other financing activities (as filed) (2016 - 2017)

Updated

Analysis

Voyager Therapeutics (VYGR) Other financing activities (as filed) (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Voyager Therapeutics 113.78 Mn -447.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2017 602,000.00
Mar 31, 2016 4,000.00
API Access

Voyager Therapeutics Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VYGR&period=max&api_key=YOUR_API_KEY